AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
SYDNEY, Oct 1 Asia Pulse - Biotech firm CSL Ltd (ASX:CSL) has received United States regulatory approval for its influenza virus vaccine, its first move into the US vaccine market.
CSL announced today that the US Food and Drug Administration had approved the vaccine, to be called Afluria in the US.
The vaccine is for active immunisation to prevent ...